Therapeutic Asset Ratings
705 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Dfn-15
Infantile Refsum Disease
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Dfn-15
Inherited Metabolic Disorders
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Dfn-15
Maroteaux Lamy Syndrome
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Dfn-15
Metachromatic Leukodystrophy
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Dfn-15
Mitochondrial Neurogastrointestingal Encephalopathy
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Dfn-15
Mucopolysaccharidosis Disorders
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Dfn-15
Multifunctional Enzyme Deficiency
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Dfn-15
Neonatal Adrenoleukodystrophy
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Dfn-15
Niemann-Pick B
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Dfn-15
Niemann-Pick C Subtype 2
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Dfn-15
Peroxisomal Disorders
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Dfn-15
Recessive Leukodystrophies
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Dfn-15
Severe Osteopetrosis
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Dfn-15
Sly Syndrome
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Dfn-15
Sphingolipidoses
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Dfn-15
Sphingomyelin Deficiency
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Dfn-15
Zellweger Syndrome
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Epirubicin
Autologous Stem Cell Transplant
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
ETOPOSIDE
Autologous Stem Cell Transplant
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Evomela
Autologous Stem Cell Transplant
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Evomela
Acute Leukemia Of Ambiguous Lineage
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Evomela
CBL-Related Disorder
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Evomela
Classic Hodgkin Lymphoma
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Evomela
Central Nervous System Leukemia
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Evomela
Chromosomal Disorder
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Showing 301 to 325 of 705 assets
Previous
Page 13 of 29
Next